{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T07:18:06Z","timestamp":1770880686496,"version":"3.50.1"},"reference-count":62,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Pulmonary sarcoidosis is a multisystem disease characterized by non-caseating granulomas, and its pathogenesis involves genetic susceptibility and abnormal immune responses triggered by environmental antigens. This article reviews the immunological etiology and mechanisms of pulmonary sarcoidosis, systematically discussing its pathogenetic basis, core immune mechanisms, and the role of key immunological biomarkers (such as sIL-2R, CD4+\/CD8+ ratio in BALF, and HRCT) in diagnosis and assessment. It also outlines the step-up therapy, ranging from glucocorticoids to immunomodulators, biologic agents, and emerging anti-fibrotic therapies, aiming to provide an immunological basis for the precise diagnosis and treatment of pulmonary sarcoidosis.<\/jats:p>","DOI":"10.3389\/fmed.2026.1754491","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T06:52:57Z","timestamp":1770879177000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Diagnosis and treatment of sarcoidosis based on immunological etiology and mechanisms"],"prefix":"10.3389","volume":"13","author":[{"given":"Jingshu","family":"Zhao","sequence":"first","affiliation":[{"name":"Department of Pathogen Biology, School of Clinical and Basic Medical Sciences, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan","place":["Shandong, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lixuan","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Pathogen Biology, School of Clinical and Basic Medical Sciences, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan","place":["Shandong, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junwen","family":"Luan","sequence":"additional","affiliation":[{"name":"Department of Pathogen Biology, School of Clinical and Basic Medical Sciences, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan","place":["Shandong, China"]},{"name":"Department of Clinical Laboratory Medicine, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan","place":["Shandong, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"106564","DOI":"10.1016\/j.rmed.2021.106564","article-title":"The impact of demographic disparities in the presentation of sarcoidosis: a multicenter prospective study.","volume":"187","author":"Zhou","year":"2021","journal-title":"Respir Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"100966","DOI":"10.1016\/j.eclinm.2021.100966","article-title":"Extrapulmonary sarcoidosis with a focus on cardiac, nervous system, and ocular involvement.","volume":"37","author":"Belperio","year":"2021","journal-title":"EClinicalMedicine."},{"key":"B3","doi-asserted-by":"publisher","first-page":"103107","DOI":"10.1016\/j.jaut.2023.103107","article-title":"Pulmonary sarcoidosis: a comprehensive review: past to present.","volume":"149","author":"Belperio","year":"2024","journal-title":"J Autoimmun."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1038\/modpathol.2012.80","article-title":"Localization of propionibacterium acnes in granulomas supports a possible etiologic link between sarcoidosis and the bacterium.","volume":"25","author":"Negi","year":"2012","journal-title":"Mod Pathol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"103120","DOI":"10.1016\/j.jaut.2023.103120","article-title":"Circulating T cells in sarcoidosis have an aberrantly activated phenotype that correlates with disease outcome.","volume":"149","author":"Miedema","year":"2024","journal-title":"J Autoimmun."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1164\/rccm.202002-0251ST","article-title":"Diagnosis and detection of sarcoidosis. An official american thoracic society clinical practice guideline.","volume":"201","author":"Crouser","year":"2020","journal-title":"Am J Respir Crit Care Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1164\/ajrccm.164.10.2104046","article-title":"Clinical characteristics of patients in a case control study of sarcoidosis.","volume":"164","author":"Baughman","year":"2001","journal-title":"Am J Respir Crit Care Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/tan.14880","article-title":"Expression of specific HLA class II alleles is associated with an increased risk for active tuberculosis and a distinct gene expression profile.","volume":"101","author":"Chihab","year":"2023","journal-title":"HLA."},{"key":"B9","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.meegid.2010.02.006","article-title":"Analysis of the association between BTNL2 polymorphism and tuberculosis in Chinese Han population.","volume":"10","author":"Lian","year":"2010","journal-title":"Infect Genet Evol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1080\/17476348.2020.1784729","article-title":"Association of TGF-\u03b23 and ANXA11 with pulmonary sarcoidosis in Greek population.","volume":"14","author":"Sikorova","year":"2020","journal-title":"Expert Rev Respir Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s12931-020-01409-w","article-title":"Immunoreactivity to metal and silica associates with sarcoidosis in Dutch patients.","volume":"21","author":"Beijer","year":"2020","journal-title":"Respir Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1128\/JCM.40.1.198-204.2002","article-title":"Quantitative analysis of mycobacterial and propionibacterial DNA in lymph nodes of Japanese and European patients with sarcoidosis.","volume":"40","author":"Eishi","year":"2002","journal-title":"J Clin Microbiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1056\/NEJMoa1609214","article-title":"Fulminant myocarditis with combination immune checkpoint blockade.","volume":"375","author":"Johnson","year":"2016","journal-title":"N Engl J Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/ni.3655","article-title":"Chronic signaling via the metabolic checkpoint kinase mTORC1 induces macrophage granuloma formation and marks sarcoidosis progression.","volume":"18","author":"Linke","year":"2017","journal-title":"Nat Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e44519","DOI":"10.7554\/eLife.44519","article-title":"HIF-1\u03b1 regulates IL-1\u03b2 and IL-17 in sarcoidosis.","volume":"8","author":"Talreja","year":"2019","journal-title":"Elife."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1164\/rccm.201507-1499OC","article-title":"IFN-\u03b3-producing T-helper 17.1 cells are increased in sarcoidosis and are more prevalent than T-helper type 1 cells.","volume":"193","author":"Ramstein","year":"2016","journal-title":"Am J Respir Crit Care Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1164\/rccm.202012-4423OC","article-title":"Follicular helper-like T cells in the lung highlight a novel role of B cells in sarcoidosis.","volume":"204","author":"Bauer","year":"2021","journal-title":"Am J Respir Crit Care Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1301991","DOI":"10.3389\/fimmu.2023.1301991","article-title":"FOXP3+ regulatory T cells are associated with the severity and prognosis of sarcoidosis.","volume":"14","author":"Patterson","year":"2023","journal-title":"Front Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.chest.2021.04.032","article-title":"Inhibiting OX40 restores regulatory T-Cell function and suppresses inflammation in pulmonary sarcoidosis.","volume":"160","author":"Kumari","year":"2021","journal-title":"Chest."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1002\/ehf2.14343","article-title":"Serum angiotensin-converting enzyme levels indicating early sarcoidosis diagnosis and immunosuppressive therapy efficacy.","volume":"10","author":"Kawai","year":"2023","journal-title":"ESC Heart Fail."},{"key":"B21","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/17476348.2023.2225772","article-title":"Diagnostic accuracy of interleukin-2 receptor in sarcoidosis: a systematic review and meta-analysis.","volume":"17","author":"Qin","year":"2023","journal-title":"Expert Rev Respir Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1615\/CritRevImmunol.2025056518","article-title":"Diagnostic power of the CD4+\/CD8+ ratio and the expression of activation and memory markers in differentiating sarcoidosis from tuberculosis, idiopathic pulmonary fibrosis, and other interstitial lung diseases.","volume":"45","author":"El Fakihi","year":"2025","journal-title":"Crit Rev Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"217","DOI":"10.4274\/ThoracResPract.2025.2025-1-2","article-title":"An important question: can serum chitotriosidase enzyme predict the activity and clinical course of sarcoidosis disease?","volume":"26","author":"\u015eahino\u011flu","year":"2025","journal-title":"Thorac Res Pract."},{"key":"B24","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.cca.2019.10.010","article-title":"Combined application of angiotensin converting enzyme and chitotriosidase analysis improves the laboratory diagnosis of sarcoidosis.","volume":"500","author":"Enyedi","year":"2020","journal-title":"Clin Chim Acta."},{"key":"B25","doi-asserted-by":"publisher","first-page":"367","DOI":"10.5578\/tt.20239605","article-title":"The role of serum and bronchoalveolar lavage fluid chitotriosidase activity on diagnosis, disease characteristics and prognosis of sarcoidosis.","volume":"71","author":"K\u00f6yc\u00fc Buhari","year":"2023","journal-title":"Tuberk Toraks."},{"key":"B26","doi-asserted-by":"publisher","first-page":"3028","DOI":"10.3390\/jcm9093028","article-title":"CT findings in pulmonary and abdominal sarcoidosis. implications for diagnosis and classification.","volume":"9","author":"Tana","year":"2020","journal-title":"J Clin Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"e31502","DOI":"10.1097\/MD.0000000000031502","article-title":"Value of CT spectral imaging in the differential diagnosis of sarcoidosis and Hodgkin\u2019s lymphoma based on mediastinal enlarged lymph node: a STARD compliant article.","volume":"101","author":"Cao","year":"2022","journal-title":"Medicine."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1174518","DOI":"10.3389\/fmed.2023.1174518","article-title":"From Karl Wurm and Guy Scadding\u2019s staging to 18F-FDG PET\/CT scan phenotyping and far beyond: perspective in the evading history of phenotyping in sarcoidosis.","volume":"10","author":"Papiris","year":"2023","journal-title":"Front Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2174\/1573405614666180528101755","article-title":"FDG-PET\/CT assessment of pulmonary sarcoidosis: a guide for internists.","volume":"15","author":"Tana","year":"2019","journal-title":"Curr Med Imaging Rev."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1007\/s00330-024-10949-4","article-title":"Meta-analysis of [18F]FDG-PET\/CT in pulmonary sarcoidosis.","volume":"35","author":"Donnelly","year":"2025","journal-title":"Eur Radiol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1183\/09031936.00088612","article-title":"Imaging the inflammatory activity of sarcoidosis.","volume":"41","author":"Keijsers","year":"2013","journal-title":"Eur Respir J."},{"key":"B32","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/RLU.0000000000006212","article-title":"Prognostic implications of volume-based quantitative 18F-FDG PET\/CT biomarkers in pulmonary sarcoidosis.","volume":"51","author":"Shao","year":"2026","journal-title":"Clin Nucl Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1159\/000505653","article-title":"The role of urinary calcium and chitotriosidase in a cohort of chronic sarcoidosis patients.","volume":"99","author":"Cameli","year":"2020","journal-title":"Respiration."},{"key":"B34","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12931-019-1263-z","article-title":"Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis.","volume":"21","author":"Bennett","year":"2020","journal-title":"Respir Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"568020","DOI":"10.3389\/fmed.2020.568020","article-title":"Hypercalciuria in sarcoidosis: a specific biomarker with clinical utility.","volume":"7","author":"Cameli","year":"2020","journal-title":"Front Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"885","DOI":"10.4103\/IJO.IJO_1151_23","article-title":"Evolving Fuchs\u2019 uveitis - a diagnostic challenge.","volume":"72","author":"Kawali","year":"2024","journal-title":"Indian J Ophthalmol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1097\/OPX.0000000000001912","article-title":"Case report: multiple ocular manifestations assisted in the diagnosis of systemic sarcoidosis.","volume":"99","author":"Zhu","year":"2022","journal-title":"Optom Vis Sci."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1136\/bjophthalmol-2018-313356","article-title":"Revised criteria of International Workshop on ocular sarcoidosis (IWOS) for the diagnosis of ocular sarcoidosis.","volume":"103","author":"Mochizuki","year":"2019","journal-title":"Br J Ophthalmol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.3390\/microorganisms9081668","article-title":"Immunohistochemical detection of propionibacterium acnes in granulomas for differentiating sarcoidosis from other granulomatous diseases utilizing an automated system with a commercially available PAB antibody.","volume":"9","author":"Isshiki","year":"2021","journal-title":"Microorganisms."},{"key":"B40","doi-asserted-by":"publisher","first-page":"103179","DOI":"10.1016\/j.jaut.2024.103179","article-title":"Developmental drugs for sarcoidosis.","volume":"149","author":"Obi","year":"2024","journal-title":"J Autoimmun."},{"key":"B41","doi-asserted-by":"publisher","first-page":"190146","DOI":"10.1183\/16000617.0146-2019","article-title":"Delphi consensus recommendations for a treatment algorithm in pulmonary sarcoidosis.","volume":"29","author":"Rahaghi","year":"2020","journal-title":"Eur Respir Rev."},{"key":"B42","doi-asserted-by":"publisher","first-page":"2004079","DOI":"10.1183\/13993003.04079-2020","article-title":"ERS clinical practice guidelines on treatment of sarcoidosis.","volume":"58","author":"Baughman","year":"2021","journal-title":"Eur Respir J."},{"key":"B43","doi-asserted-by":"publisher","first-page":"2300198","DOI":"10.1183\/13993003.00198-2023","article-title":"High-dose (40 mg) versus low-dose (20 mg) prednisolone for treating sarcoidosis: a randomised trial (SARCORT trial).","volume":"62","author":"Dhooria","year":"2023","journal-title":"Eur Respir J."},{"key":"B44","doi-asserted-by":"publisher","first-page":"00536","DOI":"10.1183\/23120541.00536-2024","article-title":"Therapeutic doses of efzofitimod demonstrate efficacy in pulmonary sarcoidosis.","volume":"11","author":"Obi","year":"2025","journal-title":"ERJ Open Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"e12297","DOI":"10.1002\/pul2.12297","article-title":"Pulmonary hemodynamics and transplant-free survival in sarcoidosis-associated pulmonary hypertension: results from an international registry.","volume":"13","author":"Gayen","year":"2023","journal-title":"Pulm Circ."},{"key":"B46","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1056\/NEJMoa2501443","article-title":"First-line treatment of pulmonary sarcoidosis with prednisone or methotrexate.","volume":"393","author":"Kahlmann","year":"2025","journal-title":"N Engl J Med."},{"key":"B47","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1378\/chest.12-1728","article-title":"Methotrexate vs azathioprine in second-line therapy of sarcoidosis.","volume":"144","author":"Vorselaars","year":"2013","journal-title":"Chest."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1183\/09031936.00195010","article-title":"Effectiveness and safety of leflunomide for pulmonary and extrapulmonary sarcoidosis.","volume":"38","author":"Sahoo","year":"2011","journal-title":"Eur Respir J."},{"key":"B49","doi-asserted-by":"publisher","first-page":"102525","DOI":"10.1016\/j.autrev.2020.102525","article-title":"In utero exposure to Azathioprine in autoimmune disease. Where do we stand?","volume":"19","author":"Belizna","year":"2020","journal-title":"Autoimmun Rev."},{"key":"B50","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.cyto.2016.08.014","article-title":"Molecular mechanisms of action of anti-TNF-\u03b1 agents - comparison among therapeutic TNF-\u03b1 antagonists.","volume":"101","author":"Mitoma","year":"2018","journal-title":"Cytokine."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1183\/09031936.00224513","article-title":"Rituximab in the treatment of refractory pulmonary sarcoidosis.","volume":"43","author":"Sweiss","year":"2014","journal-title":"Eur Respir J."},{"key":"B52","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","article-title":"Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.","volume":"370","author":"Richeldi","year":"2014","journal-title":"N Engl J Med."},{"key":"B53","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S2213-2600(20)30036-9","article-title":"Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial.","volume":"8","author":"Wells","year":"2020","journal-title":"Lancet Respir Med."},{"key":"B54","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1186\/s12890-020-01345-x","article-title":"Role of fibrocytes and endothelial progenitor cells among low-differentiated CD34+ cells in the progression of lung sarcoidosis.","volume":"20","author":"El\u017cbieta","year":"2020","journal-title":"BMC Pulm Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12931-018-0798-8","article-title":"Fibrocytes are increased in lung and peripheral blood of patients with idiopathic pulmonary fibrosis.","volume":"19","author":"Heukels","year":"2018","journal-title":"Respir Res."},{"key":"B56","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/cei.13388","article-title":"Nicotine modulates molecules of the innate immune response in epithelial cells and macrophages during infection with M. tuberculosis.","volume":"199","author":"Valdez-Miramontes","year":"2020","journal-title":"Clin Exp Immunol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.taap.2009.10.020","article-title":"Nicotine-mediated signals modulate cell death and survival of T lymphocytes.","volume":"242","author":"Oloris","year":"2010","journal-title":"Toxicol Appl Pharmacol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/j.chest.2021.05.031","article-title":"A pilot randomized trial of transdermal nicotine for pulmonary sarcoidosis.","volume":"160","author":"Crouser","year":"2021","journal-title":"Chest."},{"key":"B59","doi-asserted-by":"publisher","first-page":"119372","DOI":"10.1016\/j.jep.2025.119372","article-title":"Jiawei Yanghe decoction alleviates pulmonary sarcoidosis by upregulating NR1D1\/2 and suppressing Th17 cells.","volume":"342","author":"Cui","year":"2025","journal-title":"J Ethnopharmacol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1165\/rcmb.2015-0212OC","article-title":"Molecular analysis of sarcoidosis granulomas reveals antimicrobial targets.","volume":"55","author":"Rotsinger","year":"2016","journal-title":"Am J Respir Cell Mol Biol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.clindermatol.2024.12.017","article-title":"Cutaneous sarcoidosis: clinical and pathologic features, molecular pathogenesis, and treatment.","volume":"43","author":"Damsky","year":"2025","journal-title":"Clin Dermatol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1016\/j.chest.2020.12.027","article-title":"Phase II investigation of the efficacy of antimycobacterial therapy in chronic pulmonary sarcoidosis.","volume":"159","author":"Drake","year":"2021","journal-title":"Chest."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1754491\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T06:52:58Z","timestamp":1770879178000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1754491\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":62,"alternative-id":["10.3389\/fmed.2026.1754491"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1754491","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,12]]},"article-number":"1754491"}}